Most recently, it has been identified that conolidine and the above derivatives act around the atypical chemokine receptor 3 (ACKR3. Expressed in identical locations as classical opioid receptors, it binds to some wide array of endogenous opioids. As opposed to most opioid receptors, this receptor acts for a scavenger and does not activate a 2nd me… Read More